REJUVENRX
Live / Registered — Registered (as of 06 May 2025)
What this means for you
Registered since 06 May 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90446720
- Registration number
- 7781520
- Mark type
- Stylized text
- Filed
- 04 Jan 2021
- Published for opposition
- 18 Mar 2025
- Registered
- 06 May 2025
- Attorney of record
- Rachel Jacques
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory muscle diseases and disorders, and central nervous system diseases and disorders, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines
Owner
- RejuvenRx Inc., Montreal, Quebec, CA
- RejuvenRx Inc., Montreal, Quebec, CA
- RejuvenRx Inc., Montreal, Quebec, CA
Prosecution history
- 06 May 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 May 2025 — REGISTERED-PRINCIPAL REGISTER
- 18 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Mar 2025 — PUBLISHED FOR OPPOSITION
- 12 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Feb 2025 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 22 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Feb 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 08 Feb 2025 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
- 08 Feb 2025 — INQUIRY TO SUSPENSION E-MAILED
- 08 Feb 2025 — SUSPENSION INQUIRY WRITTEN
- 04 Feb 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 14 Jun 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED